![TriCore Reference Laboratories](/news-release/logo/426263/0/426263.png?lastModified=01%2F23%2F2017%2009%3A54%3A28&size=2)
SYSTEMIC MASTOCYTOSIS RESPONDS TO NEW DRUG
01 juil. 2016 11h12 HE
|
TriCore Reference Laboratories
ALBUQUERQUE, N.M., July 1, 2016 (GLOBE NEWSWIRE) -- Patients with a group of rare blood disorders known as advanced systemic mastocytosis have few treatment options. A drug called midostaurin showed...